KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ClearPoint Neuro (CLPT) Shares Outstanding (Weighted Average) (2018 - 2025)

ClearPoint Neuro's Shares Outstanding (Weighted Average) history spans 13 years, with the latest figure at $28.4 million for Q3 2025.

  • For Q3 2025, Shares Outstanding (Weighted Average) rose 3.03% year-over-year to $28.4 million; the TTM value through Sep 2025 reached $28.4 million, up 3.03%, while the annual FY2024 figure was $27.0 million, 9.85% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2025 was $28.4 million at ClearPoint Neuro, up from $28.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $28.4 million in Q3 2025 and bottomed at $18.9 million in Q1 2021.
  • The 5-year median for Shares Outstanding (Weighted Average) is $24.6 million (2023), against an average of $24.6 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) soared 32.07% in 2021 before it increased 0.41% in 2023.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $20.7 million in 2021, then grew by 16.63% to $24.2 million in 2022, then increased by 1.75% to $24.6 million in 2023, then grew by 9.85% to $27.0 million in 2024, then rose by 5.18% to $28.4 million in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Shares Outstanding (Weighted Average) are $28.4 million (Q3 2025), $28.0 million (Q2 2025), and $27.7 million (Q1 2025).